Media watch: SAMe targets consumers via the Web

Western Journal of Medicine

Volumn 173, Issue 4, 2000, Pages 229-230

  Shu, L ^a   Lee, Nancy P ^b  

^a Kaiser Foundation Hospitals   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

S ADENOSYLMETHIONINE; ANTIDEPRESSANT AGENT;

DEPRESSION; DIET SUPPLEMENTATION; DRUG USE; HUMAN; INTERNET; LIVER DISEASE; OSTEOARTHRITIS; SHORT SURVEY; ADVERTIZING; ARTICLE;

ADVERTISING; ANTIDEPRESSIVE AGENTS; DEPRESSION; DIETARY SUPPLEMENTS; HUMANS; INTERNET; S-ADENOSYLMETHIONINE;

EID: 0034293069     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.173.4.229     Document Type: Short Survey

References (14)

1. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders
2. Neuropharmacology of S-adenosyl-L-methionine
3. S-Adenosylmethionine and affective disorder
4. S-adenosyl-L-methionine (SAMe) as antidepressant: Meta-analysis of clinical studies
5. S-Adenosylmethionine blood levels in major depression: Changes with drug treatment
6. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine
7. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease
8. SAMe: S-Adenosylmethionine
9. Switch mechanism in affective illness and S-adenosylmethionine
10. Oral S-adenosylmethionine in depression: A randomized, double-blind, placebo-controlled trial
11. The antidepressant potential of oral S-adenosyl-L-methionine
12. Oral S-Adenosyl-L-methionine in depression
13. Toxic interaction of S-adenosylmethionine and clomipramine